Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flavonoid effects on normal and leukemic cells.

Jane L Liesveld1, Camille N Abboud, Chaohui Lu

  • 1Department of Medicine, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA. jane_liesveld@urmc.rochester.edu

Leukemia Research
|March 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Rehabilitation Utilization After CAR T-Cell Therapy.

Transplantation and cellular therapy·2026
Same author

Patient and oncologist expectations of functional prognosis among older adults with acute myeloid leukemia.

Blood advances·2026
Same author

All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.

The New England journal of medicine·2026
Same author

Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.

European journal of haematology·2026
Same author

Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function.

Signal transduction and targeted therapy·2026
Same author

Diverticulitis in Pregnancy Is Associated with High Complication Rates.

Surgical infections·2026
Same journal

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026
Same journal

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026
Same journal

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026
Same journal

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026
Same journal

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026
Same journal

CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide database.

Leukemia research·2026
See all related articles

Flavonoids like quercetin and flavopiridol show potential in treating acute myelogenous leukemia (AML) by inhibiting cancer cell growth. However, these compounds also affect normal progenitor cells, requiring further investigation for therapeutic use in AML.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Hematology

Background:

  • Flavonoids, including quercetin and flavopiridol, are known to modulate cellular processes like oxidative stress, proliferation, and apoptosis.
  • Their specific impact on acute myelogenous leukemia (AML) and normal hematopoietic progenitors requires detailed examination.

Purpose of the Study:

  • To investigate the effects of quercetin and flavopiridol on acute myelogenous leukemia (AML) cell lines and primary AML blasts.
  • To assess the impact of these flavonoids on normal hematopoietic progenitor cells (CD34+).

Main Methods:

  • Treatment of AML cell lines and primary AML blasts with quercetin and flavopiridol.
  • Evaluation of cell viability, proliferation, and apoptosis (using annexin V expression and caspase 3 activation).

Related Experiment Videos

  • Assessment of effects on normal CD34+ cells from healthy donors.

    • Main Results:

    • Both quercetin and flavopiridol demonstrated significant inhibition of growth and viability in AML cell lines and primary AML blasts.
    • These flavonoids also significantly reduced the viability and proliferation of normal CD34+ cells.
    • Flavopiridol-induced apoptosis in some AML cases was linked to caspase 3 activation.

    Conclusions:

    • Quercetin and flavopiridol exhibit cytotoxic effects against acute myelogenous leukemia cells.
    • The observed effects on normal progenitor cells suggest potential challenges for their therapeutic application in AML.
    • Further research into these flavonoid compounds may reveal therapeutic strategies for AML treatment.